Immunometabolic Reversal of Long COVID and Inflammatory Memory via Host-Directed Antiviral and Metabolic Shielding

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provokes an intense acute inflammatory response (1, 16). However, in hundreds of millions of individuals surviving the acute phase, clinical presentation frequently diverges into persistent post-acute sequelae known as Long COVID, or Post-Acute Sequelae of SARS-CoV-2 (PASC) (1, 16). With global epidemiological estimates now surpassing 400 million affected patients worldwide, Long COVID has emerged as one of the most debilitating public health crises of the modern era (1, 16). Characterized by intractable chronic fatigue, post-exertional malaise (PEM), neuro-psychiatric cognitive impairment ("brain fog"), autonomic dysregulation, and accelerated biological aging (inflammaging) in the absence of active viral replication, the syndrome imposes an immense socioeconomic and healthcare burden (1, 16). Current clinical management remains severely bottlenecked by palliative symptom management, largely because existing therapeutic models fail to address the core drivers of disease persistence (1, 16). Here, we uncover the precise molecular circuitry coupling viral persistence and metabolic stress to chronic post-viral fatigue: the SARS-CoV-2 ORF7b-c-Myc-MALAT1/NEAT1-miR-22-3p-NLRP3 axis, integrated with the SIRT6-SIRT3-LCAD/SLC25A13-mitochondrial dysfunction-associated senescence (MIDAS) axis and the p53-FBXO22-NSP5 / RIG-I / MAVS feedforward antiviral loop (1, 9, 10, 16, 17, 18, 19, 20, 21). Utilizing an expanded deterministic eight-variable non-linear ordinary differential equation (ODE) kinetic model and phase-space separatrix analysis, we establish a critical therapeutic separatrix threshold (S_"ImmunoShield" ≥2.85" a.u." ) and demonstrate how a host-directed p53/NRF2-metformin-taurine immunometabolic shield successfully dismantles pathological attractors, clears oxidized mitochondrial DNA, restores sirtuin-mediated deacetylation, and terminates inflammatory memory.

Authors

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11660933/v1
Primary Topic
Long-Term Effects of COVID-19
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Immunometabolic Reversal of Long COVID and Inflammatory Memory via Host-Directed Antiviral and Metabolic Shielding

Boominathan Lakshmanane
2 links
Research Square
Long-Term Effects of COVID-19
preprint

Immunometabolic Reversal of Long COVID and Inflammatory Memory via Host-Directed Antiviral and Metabolic Shielding

Boominathan Lakshmanane
preprint en

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provokes an intense acute inflammatory response (1, 16). However, in hundreds of millions of individuals surviving the acute phase, clinical presentation frequently diverges into persistent post-acute sequelae known as Long COVID, or Post-Acute Sequelae of SARS-CoV-2 (PASC) (1, 16). With global epidemiological estimates now surpassing 400 million affected patients worldwide, Long COVID has emerged as one of the most debilitating public health crises of the modern era (1, 16). Characterized by intractable chronic fatigue, post-exertional malaise (PEM), neuro-psychiatric cognitive impairment ("brain fog"), autonomic dysregulation, and accelerated biological aging (inflammaging) in the absence of active viral replication, the syndrome imposes an immense socioeconomic and healthcare burden (1, 16). Current clinical management remains severely bottlenecked by palliative symptom management, largely because existing therapeutic models fail to address the core drivers of disease persistence (1, 16). Here, we uncover the precise molecular circuitry coupling viral persistence and metabolic stress to chronic post-viral fatigue: the SARS-CoV-2 ORF7b-c-Myc-MALAT1/NEAT1-miR-22-3p-NLRP3 axis, integrated with the SIRT6-SIRT3-LCAD/SLC25A13-mitochondrial dysfunction-associated senescence (MIDAS) axis and the p53-FBXO22-NSP5 / RIG-I / MAVS feedforward antiviral loop (1, 9, 10, 16, 17, 18, 19, 20, 21). Utilizing an expanded deterministic eight-variable non-linear ordinary differential equation (ODE) kinetic model and phase-space separatrix analysis, we establish a critical therapeutic separatrix threshold (S_"ImmunoShield" ≥2.85" a.u." ) and demonstrate how a host-directed p53/NRF2-metformin-taurine immunometabolic shield successfully dismantles pathological attractors, clears oxidized mitochondrial DNA, restores sirtuin-mediated deacetylation, and terminates inflammatory memory.

Research Square
Good health and well-being
Long-Term Effects of COVID-19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon